Vendor, Tampa, FL
H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc.
UEI DVHKP4N619V9, CAGE 1X4B9
2 awards and $82,034 obligated between July 9, 2026 and August 24, 2026, 0% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Testing Laboratories and ServicesNAICS 541380 | $147,750 |
| All Other Professional, Scientific, and Technical ServicesNAICS 541990 | -$65,716 |
How it wins
Awards by competition, set-aside and type.
| Not Competed Under SAP | 1 |
| Not Competed | 1 |
| Purchase Order | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N98026P00992Purchase Order, July 9, 2026, Not Competed Under SAP, 1 offers | National Institutes of Health OlaoNational Institutes of Health | NCI - Corrective Editing of Splicing Factor Mutant Myelodysplastic Syndromes and Chronic Myelomonocytic LeukemiaNAICS 541380, PSC Q301 | $147,750 |
| 75N91021P00898Purchase Order, August 24, 2026, Not Competed, 1 offers | NIH NCINational Institutes of Health | To Administratively De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in PreparatiNAICS 541990, PSC R405 | -$65,716 |
- Product and service codes
- Q301 Reference Laboratory TestingR405 Operations Research and Quantitative Analysis Services
- Transactions
- 2 across 2 awards